Feline injection site sarcoma: immunohistochemical characteristics

被引:19
作者
Carneiro, Carolina S. [1 ]
de Queiroz, Genilson F. [2 ]
Pinto, Ana C. B. C. F. [1 ]
Dagli, Maria L. Z. [3 ]
Matera, Julia M. [1 ]
机构
[1] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Vet Surg, Sao Paulo, Brazil
[2] Fed Rural Univ Semiarid, Dept Anim Sci, Av Francisco Mota 572, BR-59625900 Mossoro, Brazil
[3] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
VACCINE-ASSOCIATED FIBROSARCOMA; CYCLOOXYGENASE-2; EXPRESSION; C-KIT; HISTOLOGY; DESMIN; TUMORS; CATS;
D O I
10.1177/1098612X18774709
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objectives Feline injection site sarcoma (FISS) is a rapid growing locally aggressive tumor with a low metastatic rate. Its histologic features are clearly defined, but there are few studies regarding its immunohistochemical characteristics. The present study investigated the immunohistochemical characteristics of 21 cases of FISS. Methods FISSs from 12 male and nine female cats, 20 mixed-breed and one Siamese, were included in the study. After histopathological diagnosis, additional histologic sections were immunostained for vimentin, cytokeratin, desmin, S100 protein, viral feline leukemia virus (FeLV) particles, cyclooxygenase 2 (COX-2) and c-KIT. Positive and negative controls were adopted accordingly. Immunostainings were classified as positive or negative according to the number of positive cells from a total of 1000 cells per tumor section. Results Histopathologic diagnosis of the tumors revealed 18 (85.7%) fibrosarcomas and three (14.3%) other sarcomas; four fibrosarcomas (22.2%) were grade III, five (27.8%) were grade II and nine (50.0%) were grade I. Two sarcomas were grade III and one was grade II. Seventeen (81%) tumors were negative for desmin. All samples were positive for vimentin. Twenty tumors (95.2%) were positive for S-100 protein. Positivity for c-KIT was observed in four (19%) samples; COX-2 was positive in 13 (61.9%) and FeLV viral particles were positive in nine (42.9%) FISSs. Conclusions and relevance Immunohistochemical findings of FISSs revealed positive immunostainings for desmin, vimentin, S-100 protein, c-KIT, COX-2 and FeLV viral particles.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 34 条
  • [1] Comparison of the histology and immunohistochemistry of vaccination-site and non-vaccination-site sarcomas from cats in New Zealand
    Aberdein, D.
    Munday, J. S.
    Dyer, C. B.
    Knight, C. G.
    French, A. F.
    Gibson, I. R.
    [J]. NEW ZEALAND VETERINARY JOURNAL, 2007, 55 (05) : 203 - 207
  • [2] Many actions of cyclooxygenase-2 in cellular dynamics and in cancer
    Cao, Y
    Prescott, SM
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) : 279 - 286
  • [3] Feline vaccine-associated fibrosarcoma: Morphologic distinctions
    Couto, SS
    Griffey, SM
    Duarte, PC
    Madewell, BR
    [J]. VETERINARY PATHOLOGY, 2002, 39 (01) : 33 - 41
  • [4] Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats
    Dank, G
    Chien, MB
    London, CA
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (08) : 1129 - 1133
  • [5] Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs
    de Almeida, EMP
    Piché, C
    Sirois, J
    Doré, M
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (07) : 867 - 875
  • [6] Feline vaccine-associated fibrosarcoma induced by aluminium compound in two cats:: Short communication
    Deim, Zoltan
    Palmai, Nimrod
    Cserni, Gabor
    [J]. ACTA VETERINARIA HUNGARICA, 2008, 56 (01) : 111 - 116
  • [7] Feline fibrosarcomas at vaccination sites and non-vaccination sites
    Doddy, FD
    Glickman, LT
    Glickman, NW
    Janovitz, EB
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 1996, 114 (02) : 165 - 174
  • [8] Cyclooxygenase-2 expression in canine mammary tumors
    Doré, M
    Lanthier, I
    Sirois, J
    [J]. VETERINARY PATHOLOGY, 2003, 40 (02) : 207 - 212
  • [9] ESPLIN DG, 1993, J AM VET MED ASSOC, V202, P1245
  • [10] Fosslien E, 2001, ANN CLIN LAB SCI, V31, P325